Public-registry trials using SPI-62 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
| Trial | Sponsor | Condition | Phase | Sites |
| SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome | Sparrow Pharmaceuticals | Cushing's Syndrome I | PHASE2 | 12 |
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
